Skip to main content
Medistim ASA (OSL:MEDI)
Norway flag Norway · Delayed Price · Currency is NOK
212.00
-4.00 (-1.85%)
At close: Mar 9, 2026

Medistim ASA Revenue

In the year 2025, Medistim ASA had annual revenue of 699.77M NOK with 25.82% growth. Medistim ASA had revenue of 182.30M in the quarter ending December 31, 2025, with 25.98% growth.

Revenue
699.77M
Revenue Growth
+25.82%
P/S Ratio
5.54
Revenue / Employee
4.54M
Employees
154
Market Cap
3.88B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025699.77M143.60M25.82%
Dec 31, 2024556.16M35.05M6.73%
Dec 31, 2023521.11M34.85M7.17%
Dec 31, 2022486.26M68.45M16.38%
Dec 31, 2021417.82M61.61M17.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nordhealth AS 601.75M
Photocure ASA 532.58M
ArcticZymes Technologies ASA 118.21M
Nykode Therapeutics AS 4.57M
Vistin Pharma ASA 452.29M
Omda AS 495.69M
Lytix Biopharma AS 377.00K
Circio Holding ASA 123.00K
Revenue Rankings

Medistim ASA News

More News